BT
Brian Tambi
Director

Brian Tambi insider trades: Insys Therapeutics (INSY) stock buys and sales

Director, Insys Therapeutics Last trade May 10, 2018 26 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2014
3
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Brian reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 10, 2018INSY↓ Sell$1.1M
Nov 21, 2017AKRX↓ Sell$504K
Aug 4, 2017AKRX↓ Sell$172K
Jun 2, 2016AKRX↓ Sell$768K
May 27, 2015INSY↓ Sell$294K
May 20, 2015INSY↓ Sell$307K
Dec 15, 2014AKRX↓ Sell$50K
Sep 12, 2014AKRX↓ Sell$524K
Jun 13, 2014AKRX↑ Buy$28K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Brian Tambi's insider trades

Brian Tambi is a director at Insys Therapeutics (INSY). Since Jun 13, 2014, Brian has reported 1 open-market purchase worth $28K and 8 sales worth $3.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (18 filings), option exercises (5 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INSY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.